v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Assets    
Cash $ 2,401,831 $ 4,238,006
Digital Assets (Note 2) 3,416,256 888,026
Finance receivables 19,221 26,802
Marketable securities (Note 5) 17,860 4,290
Notes receivable from Seastar Medical Holding Corporation (Note 5)   3,807,749
Receivable from sale of Symbiont assets 200,000  
Prepaid expenses and other assets 4,067,212 1,233,322
Income tax receivable 31,187 293,466
Current assets 10,153,567 10,491,661
Fixed assets, net (Note 3) 24,519,610 27,272,374
Deposit on mining equipment (Note 4) 20,837 525,219
Hosting services deposit (Note 4)   2,200,452
Notes receivable from Seastar Medical Holding Corporation (Note 5) 1,440,498  
Long-term investments - debt security (Note 5)   2,402,542
Less: Allowance for losses on debt security (Note 5)   (1,052,542)
Long-term investments - debt security, net (Note 5)   1,350,000
Long-term investments - equity securities (Note 5) 156,992 464,778
Investment in Seastar Medical Holding Corporation (Note 5) $ 1,145,486 $ 10,608,750
Investment, Issuer Affiliation [Extensible Enumeration] us-gaap:InvestmentAffiliatedIssuerMember us-gaap:InvestmentAffiliatedIssuerMember
Operating lease - right of use assets (Note 7) $ 189,009 $ 265,658
Other assets 86,798 10,726
Long-term assets 27,559,230 42,697,957
Total assets 37,712,797 53,189,618
Liabilities and stockholders' equity    
Accounts payable and accrued expenses 2,064,909 1,570,906
Note payable - short-term (Note 6) 567,586 475,775
Due to related parties (Note 9) $ 22,845 $ 75,488
Other Liability, Current, Related Party, Type [Extensible Enumeration] Related Party [Member] Related Party [Member]
Current portion of lease liability (Note 7) $ 110,384 $ 90,823
Total current liabilities 2,765,724 2,212,992
Lease liability - net of current portion (Note 7) 85,775 179,397
Long-term liabilities 85,775 179,397
Total liabilities 2,851,499 2,392,389
Stockholders' equity (Note 10)    
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of December 31, 2023 and December 31, 2022
Common stock, par value $.001; 350,000,000 shares authorized; 2,492,964 shares issued and outstanding as of December 31, 2023 and 2,232,964 as of December 31, 2022 2,493 2,233
Additional paid-in capital 95,145,376 92,206,200
Accumulated deficit (58,961,461) (43,017,207)
Total LM Funding America stockholders' equity 36,186,408 49,191,226
Non-controlling interest (1,325,110) 1,606,003
Total stockholders' equity 34,861,298 50,797,229
Total liabilities and stockholders’ equity $ 37,712,797 $ 53,189,618

Source

HTML PDF
ZIP